Verition Fund Management LLC Aura Biosciences, Inc. Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$7.09 - $9.24 $3,580 - $4,666	-505 Reduced 0.33%	151,681 $1.19 Million
Q4 2023 Feb 14, 2024	BUY	$7.02 - $11.98 $709,757 - $1.21 Million	101,105 Added 197.93%	152,186 $1.35 Million
Q3 2023 Nov 14, 2023	SELL	$8.97 - $12.38 $100,150 - $138,222	-11,165 Reduced 17.94%	51,081 $458,000
Q2 2023 Aug 14, 2023	BUY	$8.51 - $13.33 $344,433 - $539,518	40,474 Added 185.9%	62,246 $768,000
Q1 2023 May 15, 2023	BUY	$8.88 - $12.11 $193,335 - $263,658	21,772 New	21,772 $202,000

37.6M

122K

38.5K

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $268M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.